arXiv:2608.22097v1 Announce Type: cross
Abstract: Pathologic complete response (pCR) is a strong neoadjuvant endpoint, yet 5-15% of complete responders recur and clinical/genomic variables do not rel...
By Dattatreya Kantha, Murray H. Loew
arXiv:2607. 13984v1 Announce Type: cross Abstract: Longitudinal tumor measurements, dropout information, and genetic covariates provide complementary information about treatment response, but integrating these data sources within a single population modeling framework remains challenging.
By Anders Sj\"oberg, Nils Olsson, Marcus Baaz, Mats Jirstrand
arXiv:2608. 03145v1 Announce Type: new Abstract: Deep learning models can predict cancer recurrence from H&E stained slides, but the localized molecular states underlying these predictions remain largely obscured.
By Yesung Cho, Ji Hwan Park, Chanil Kim, Hyewon Kim, Honglan Li, Yumin Lee, Geongyu Lee, Sujeong Hong, Seong Min Park, Yoonyoung Lee, Hee Sool Rho, Sumin Lee, Amos Chungwon Lee, Changhwan Lee, Hwanyoung Shim, Hyunwook Kim, Hyeji Shin, Sanha Park, Jihoon Yu, Yoon Hee Shin, Sooheon Kim, Hyunjin Park, Seung Min Park, Sangwan Kim, Yujung Kim, Sung-Im Do, Eun-Young Kim, Dongmyung Shin, Jongbae Park, In-Gu Do
arXiv:2608.24688v1 Announce Type: new
Abstract: Precision oncology necessitates a longitudinal model of patient state that captures cancer evolution and treatment over time, integrating multimodal ob...
By Eugene Vorontsov, Yi Kan Wang, Alican Bozkurt, Adam Casson, Ludmila Tydlitatova, Michal Zelechowski, Ezra E. W. Cohen, Jyoti D. Patel, Max Banaszak, Caitlin McWilliams, Shane Colley, Kate Sasser, Ryan Fukushima, Eric Lefkofsky, Razik Yousfi, Siqi Liu
arXiv:2609.26105v1 Announce Type: cross
Abstract: Prediction of pathological complete response before neoadjuvant chemotherapy may facilitate more tailored therapeutic planning for breast cancer pati...
By Pablo Garc\'ia Marcos, Paula Puerta Gonz\'alez, Guillermo Lorenzo, H\'ector G\'omez, Covadonga del Camino, Ad\'an Rodr\'iguez, Ignacio Pel\'aez, Angel Rio-Alvarez, V\'ictor M. Gonz\'alez
The study examined whether embeddings from four foundation models—Mammo-CLIP, HOPPR, MedImageInsight, and BiomedCLIP—could detect pre‑diagnostic changes in screening mammograms. Using 1,773 biopsied women and matched controls, the researchers measured the speed of movement along a data‑derived “cancer direction” in embedding space over successive screening intervals. They found that embeddings from clinically grounded models (Mammo‑CLIP, HOPPR, MedImageInsight) showed faster drift in malignant cases compared to controls, while the general biomedical model BiomedCLIP did not, indicating that foundation model embeddings can encode early tissue changes without task‑specific fine‑tuning.
By Kalina P. Slavkova, Eric Brattain, Aditya Gowd, Akash Pattnaik, Jean-Benoit Delbrouck, Matthew Morgan, Julie Bauml, Javid Abderezaei, Khan Siddiqui